DisGeNET

DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.

Source Last Updated
DisGeNET July 29, 2024
Displaying entries 6301 - 6325 of 62743 in total
Disease ID Disease Name Gene Symbol Gene ID Gene Name UniProt ID ▼
C0003873 Rheumatoid Arthritis ST6GALNAC5 81849 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 Q9BVH7
C1956346 Coronary Artery Disease ST6GALNAC5 81849 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 Q9BVH7
C0010054 Coronary Arteriosclerosis ST6GALNAC5 81849 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 Q9BVH7
C0006826 Malignant Neoplasms ST6GALNAC5 81849 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 Q9BVH7
C0027651 Neoplasms ST6GALNAC5 81849 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 Q9BVH7
C0007867 Cervix Diseases ST6GALNAC5 81849 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 Q9BVH7
C0024299 Lymphoma ST6GALNAC5 81849 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 Q9BVH7
C0006142 Malignant neoplasm of breast ST6GALNAC5 81849 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 Q9BVH7
C0010068 Coronary heart disease ST6GALNAC5 81849 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 Q9BVH7
C1306459 Primary malignant neoplasm ST6GALNAC5 81849 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 Q9BVH7
C0017638 Glioma ST6GALNAC5 81849 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 Q9BVH7
C0007847 Malignant tumor of cervix ST6GALNAC5 81849 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 Q9BVH7
C0206708 Cervical Intraepithelial Neoplasia ST6GALNAC5 81849 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 Q9BVH7
C0302592 Cervix carcinoma ST6GALNAC5 81849 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 Q9BVH7
C0002395 Alzheimer's Disease EDEM2 55741 ER degradation enhancing alpha-mannosidase like protein 2 Q9BV94
C0042133 Uterine Fibroids EDEM2 55741 ER degradation enhancing alpha-mannosidase like protein 2 Q9BV94
C0023267 Fibroid Tumor EDEM2 55741 ER degradation enhancing alpha-mannosidase like protein 2 Q9BV94
C0036341 Schizophrenia EDEM2 55741 ER degradation enhancing alpha-mannosidase like protein 2 Q9BV94
C0036341 Schizophrenia MECR 51102 mitochondrial trans-2-enoyl-CoA reductase Q9BV79
C0029124 Optic Atrophy MECR 51102 mitochondrial trans-2-enoyl-CoA reductase Q9BV79
C0013384 Dyskinetic syndrome MECR 51102 mitochondrial trans-2-enoyl-CoA reductase Q9BV79
C0009402 Colorectal Carcinoma MECR 51102 mitochondrial trans-2-enoyl-CoA reductase Q9BV79
C0752202 Childhood Onset Dystonias MECR 51102 mitochondrial trans-2-enoyl-CoA reductase Q9BV79
C0008489 Chorea MECR 51102 mitochondrial trans-2-enoyl-CoA reductase Q9BV79
C0007789 Cerebral Palsy MECR 51102 mitochondrial trans-2-enoyl-CoA reductase Q9BV79

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024